UBS Group’s CapForce IBD Breakout Opportunities ETF BOUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-330
Closed -$13K – 10470
2026
Q1
$13K Buy
330
+98
+42% +$3.85K ﹤0.01% 8232
2025
Q4
$8.42K Sell
232
-1,096
-83% -$41.1K ﹤0.01% 8362
2025
Q3
$51.8K Sell
1,328
-444
-25% -$16.7K ﹤0.01% 7538
2025
Q2
$64.8K Buy
1,772
+1,511
+579% +$52.2K ﹤0.01% 7568
2025
Q1
$9.47K Buy
261
+105
+67% +$4.09K ﹤0.01% 8688
2024
Q4
$6.1K Buy
156
+127
+438% +$4.95K ﹤0.01% 8595
2024
Q3
$1.06K Sell
29
-66
-69% -$2.35K ﹤0.01% 8730
2024
Q2
$3.31K Buy
+95
New +$3.3K ﹤0.01% 8234
2024
Q1
– Sell
-346
Closed -$11.4K – 9335
2023
Q4
$11.4K Sell
346
-30
-8% -$923 ﹤0.01% 7391
2023
Q3
$11.4K Sell
376
-454
-55% -$14.4K ﹤0.01% 7059
2023
Q2
$26.8K Buy
830
+712
+603% +$21.7K ﹤0.01% 6754
2023
Q1
$3.68K Sell
118
-1,129
-91% -$34.4K ﹤0.01% 8291
2022
Q4
$36.9K Buy
1,247
+84
+7% +$2.52K ﹤0.01% 7037
2022
Q3
$33K Buy
1,163
+1,116
+2,374% +$34.6K ﹤0.01% 6754
2022
Q2
$1K Sell
47
-1,232
-96% -$42.3K ﹤0.01% 9822
2022
Q1
$48K Buy
+1,279
New +$46.8K ﹤0.01% 6532
2021
Q4
– Sell
-1,583
Closed -$54K – 10265
2021
Q3
$54K Buy
1,583
+804
+103% +$27.8K ﹤0.01% 6272
2021
Q2
$26K Sell
779
-1,201
-61% -$40.2K ﹤0.01% 7067
2021
Q1
$66K Buy
1,980
+1,913
+2,855% +$65.7K ﹤0.01% 6273
2020
Q4
$2K Sell
67
-886
-93% -$24.2K ﹤0.01% 8081
2020
Q3
$22K Sell
953
-797
-46% -$18.7K ﹤0.01% 6229
2020
Q2
$39K Sell
1,750
-167
-9% -$3.46K ﹤0.01% 6079
2020
Q1
$35K Buy
1,917
+22
+1% +$443 ﹤0.01% 6100
2019
Q4
$40K Buy
1,895
+507
+37% +$10.1K ﹤0.01% 6471
2019
Q3
$27K Buy
+1,388
New +$29K ﹤0.01% 6542
2019
Q2
– Sell
-1,651
Closed -$33K – 7860
2019
Q1
$33K Buy
+1,651
New +$31.9K ﹤0.01% 5860

Other funds holding BOUT

UBS Group's BOUT Position: Q2 2026 in Review

UBS Group sold out of CapForce IBD Breakout Opportunities ETF (BOUT) in Q2 2026, closing a stake of 330 shares — an estimated $13K sold.

UBS Group first reported a position in BOUT in Q1 2019 and held it in 26 quarters. The position peaked at $66K in Q1 2021. 12 funds tracked by Wall St. Rank hold BOUT as of Q2 2026.

  • UBS Group reported no remaining CapForce IBD Breakout Opportunities ETF position as of Q2 2026 after selling out during the quarter.
  • UBS Group sold 330 CapForce IBD Breakout Opportunities ETF shares in Q2 2026, an estimated $13K.
  • UBS Group first reported a position in CapForce IBD Breakout Opportunities ETF in Q1 2019 and held it in 26 quarters.
  • UBS Group's CapForce IBD Breakout Opportunities ETF position peaked at $66K in Q1 2021.
  • 12 funds tracked by Wall St. Rank held CapForce IBD Breakout Opportunities ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.